CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A universal chemoenzymatic labeling system for profiling cell-cell interactions and potentiating targeted tumor immunotherapy.
A universal chemoenzymatic labeling system for profiling cell-cell interactions and potentiating targeted tumor immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
细胞膜上的分子决定了细胞如何与其环境及其他细胞相互作用,并作为肿瘤免疫治疗的靶点。酶催化的邻近标记已成为研究细胞间通讯和功能化细胞膜的关键工具。为了实现更精确、高效的细胞膜工程酶标记,进一步研究新型标记策略至关重要。
在本研究中,我们开发了一种利用 SrtA-SpA C 的精确化学酶标记策略,由抗体介导(Ab-SS),作为检测细胞-细胞相互作用和构建用于肿瘤免疫治疗的抗体-细胞偶联物(ACCs)的通用方法。首先,我们成功采用 Ab-SS 策略在复杂细胞环境中标记特定细胞群体。
此外,该方法可精确扩展至标记与靶细胞相互作用的细胞群。利用 Ab-SS 系统,我们报道了一种有效的 ACC 平台,作为嵌合抗原受体技术的替代方案。该平台精确地将肿瘤靶向抗体装备到免疫细胞上,以引导其识别和攻击癌细胞。
总之,鉴于其灵活性和强大功能,Ab-SS 酶标记系统提供了一种通用策略,通过邻近标记促进细胞功能研究并推进靶向免疫细胞治疗。
Molecules on the cell membrane dictate how cells interact with their environment and other cells and serve as the target for tumor immunotherapy. Enzyme-catalyzed proximity labeling has become a pivotal tool for studying intercellular communication and functionalizing cell membranes. To enable more precise and efficient enzymatic labeling for cell membrane engineering, further investigation of novel labeling strategies is crucial.
In this study, we developed a precise chemoenzymatic labeling strategy using SrtA-SpA C , mediated by antibodies (Ab-SS), as a general method for detecting cell-cell interactions and constructing antibody-cell conjugates (ACCs) for tumor immunotherapy. Firstly, we successfully employed the Ab-SS strategy to label specific cell populations within complex cellular environments.
Furthermore, this method can be precisely extended to label cell groups that interact with the target cells. Employing the Ab-SS system, we report a potent ACC platform as an alternative to chimeric antigen receptor technology. This platform precisely equips immune cells with tumor-targeting antibodies to direct their recognition and attack against cancer cells.
Collectively, given its flexibility and robust functionality, the Ab-SS enzymatic labeling system provides a generalized strategy for facilitating research on cellular function and advancing targeted immune cell therapies through proximity labeling.
MEMBER ACCOUNT
登录成功会直接打开下一页。